Why do we need this research?
1 in 4 pregnancies end in loss and many parents never find out why. We believe this needs to change.
To find out more about the causes of miscarriage, our researchers looked at the effects of bacteria on pregnancy. They showed that lower amounts of a type of bacteria called Lactobacillus in the vagina were connected to increased inflammation and a higher risk of miscarriage. They found that some women with low levels of Lactobacillus did have healthy pregnancies, but that these women did not have as much inflammation in the vagina.
Our researchers now want to understand how an imbalance in vaginal bacteria leads to miscarriage and whether this can be treated. They also want to find a better way of diagnosing problems with vaginal bacteria.
What’s happening in this project?
By carrying out studies in the lab, our researchers hope to work out why low amounts of Lactobacillus bacteria in the vagina can cause miscarriage. There are several proposed mechanisms that will be explored, including the possibility that miscarriage occurs because of inflammation, or that bacteria from the vagina reach the womb and affect implantation and the formation of the placenta.
As well as these studies, our researchers want to find a better way of detecting whether a woman has a bacterial imbalance in her vagina. At the moment, the tests that are used are too slow and expensive, while other tests do not give enough detail to be useful. In collaboration with other researchers, our team have developed a new way of looking at the bacteria present in the vagina by using something called Desorption Electrospray Ionisation Mass Spectrometry (DESI-MS). Our team will now test and develop the DESI-MS method further, and hope that in the future it can be used routinely in clinical settings to identify those women who are more likely to miscarry.
Finally, our researchers want to look at whether it is possible to use probiotic treatments to increase the amount of Lactobacillus bacteria in the vagina and prevent miscarriage. The team are planning two clinical trials of a probiotic called Lactin V – one in women with recurrent miscarriage and one in women who have had one previous miscarriage.
What difference will this project make?
This project will help us understand more about why an imbalance in vaginal bacteria can lead to miscarriage. Also, by developing a quick and easy test to detect an imbalance, it will make it much easier for clinicians to detect the women who are more likely to have a miscarriage and who would benefit from treatment. We hope that our clinical trials will show that probiotic treatment can help these women, ultimately leading to a reduction in the number of women having to endure a devastating miscarriage.